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Abbreviations:  
AP, action potential; AEA, anandamide; BTX, batrachotoxin; IL,Ca, L-type Ca2+ current; metAEA, 
methanandamide; NAEs, N-acylethanolamines; PTX, pertussis toxin; INa, Na+ current; TTX, 
tetrodotoxin; VGSC, voltage gated sodium channel; VGCC, voltage gated calcium channel.  
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Summary 
Background and purpose: Endocannabinoid Anandamide (N-arachidonoyl ethanolamide; AEA) has 
been shown to cause negative inotropic and antiarrhythmic effects in ventricular myocytes. 
Experimental approach: Whole-cell patch clamp technique and radioligand binding methods were 
used to test the effect of anandamide in rat ventricular myocytes. 
Key results:  In the presence of 1-10 µM AEA, suppression of both Na+ and L-type Ca2+ channels was 
observed. Inhibition of Na+ channels was voltage and pertussis toxin (PTX) - independent. Radioligand 
binding studies indicated that specific binding of [3H] Batrachotoxin (BTX) to ventricular muscle 
membranes was also inhibited significantly by metAEA, a non-metabolized AEA analogue. In controls 
and  in  presence  of  10  μM  metAEA,  Bmax  values  were  76  ±  6  and  41  ±  4  fM,  and  KD values were 32 ± 
4 and 35 ± 3 nM, respectively. Further studies on L-type Ca2+ channels indicated that AEA potently 
inhibits these channels with IC50 of 0.1 µM in a voltage- and PTX- independent manner. AEA inhibited 
maximal amplitudes without affecting the kinetics of Ba2+ currents. MetAEA also inhibited Na+ and L-
type Ca2+ currents. Radioligand studies indicated that specific binding of [3H]Isradipine, was inhibited 
significantly by metAEA. In controls and in presence of 10 μM  metAEA,  Bmax    were  146  ±  19  and  98  
± 24 fM/mg, and KD values were 63 ± 4 and 86 ± 14 pM, respectively.  
Conclusion: Results indicate that AEA inhibits the function of voltage-dependent Na+ and L-type Ca2+ 
channels in rat ventricular myocytes in a manner independent of CB1 and CB2 receptor activation. 
Keywords: Endocannabinoid, Anandamide, Na+ channel, L-type Ca2+ channel, ventricular myocyte.  
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INTRODUCTION 
Endocannabinoids are a group of polyunsaturated fatty acid-based compounds that mimic most 
of the effects tetrahydrocannabinol, the active ingredient of the marijuana plant Cannabis sativa. N-
arachidonoyl ethanolamide (AEA) or Anandamide and 2-arachidonylglycerol are the most widely 
studied endogenous cannabinoids (Di Marzo et al., 2005; Hanus and Mechoulam, 2010). In recent 
years, extensive research focusing on the biological actions of these compounds indicated that 
endocannabinoids have important regulatory roles in several physiological and pathological conditions 
(Pacher et al., 2006; Di Marzo et al., 2005; Pertwee et al., 2010). It has been shown that 
endocannabinoid system consists of at least the endocannabinoid receptors (such as CB1 and CB2 
cannabinoid receptors), the enzymes regulating the synthesis (such as phospholipase-D, and 
monoacylglycerol lipase), and the degradation (such as fatty-acid amide hydrolase and lipases) 
processes, and the proteins involved in their transport across the biological membranes (Di Marzo et 
al., 2005; Pertwee et al., 2010). CB1 receptors are located in the brain and several peripheral tissues 
including the heart and the vasculature (Pertwee et al., 2010). The CB2 receptors, on the other hand, are 
expressed primarily in the immune system but recently their presence in the brain, myocardium, and 
smooth muscle cells have also been demonstrated (Pertwee et al., 2010).  
Recent studies suggest that endocannabinoids have important modulatory roles on the function 
of cardiovascular system under various pathological conditions, such as hypertension, myocardial 
infarction and heart failure [for recent reviews, (Batkai and Pacher, 2009; Montecucco and Di Marzo, 
2012)]. AEA, the most studied endocannabinoid, has complex set of actions on cardiac functions. 
Experiments with AEA performed in isolated Langendorff rat hearts and in isolated, electrically 
stimulated human atrial appendages (Ford et al., 2002; Bonz et al., 2003) have revealed a negative A
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inotropic effect which may underlie its ability to decrease cardiac output as observed in studies 
performed in vivo (Wagner et al., 2001). Moreover, AEA and other cannabinoids have been reported to 
have antiarrhythmic effects in in vivo animal models (Krylatov et al., 2002; Ugdyzhekova et al., 2001). 
In a recent study a weak protective effect of endocannabinoids during the late stages of ischemia has 
been suggested to be mediated by CB1 receptors (Andrag and Curtis, 2013). Another study reported 
that AEA potently inhibits the function of L-type Ca2+ channels by activating CB1 receptors in rat 
cardiomyocytes (Li et al., 2009). However, electrophysiological mechanisms underlying these cardiac 
actions of AEA remain largely unknown. We hypothesized that some of the negative inotropic and 
antiarrhythmic actions of AEA can be mediated by the modulation of voltage-gated inward Na+ and 
Ca2+ channels. Thus, in the present study, using whole-cell patch clamp and radioligand binding 
methods, we investigated the actions of AEA on these major inward currents underlying the shape of 
the action potential in acutely dissociated rat ventricular myocytes. 
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Methods 
Ventricular myocyte isolation: This study was carried out in accordance with the recommendations in 
the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The work 
was performed with approval of Animal Research Ethics Committee of the College of Medicine and 
Health Sciences, UAE University. All studies involving animals are reported in accordance with the 
ARRIVE guidelines for reporting experiments involving animals (Kilkenny et al., 2010; McGrath et 
al., 2010).The original stocks of Wistar rats were purchased from Harlan Laboratories (Oxon, 
England). Animals were bred at our own Animal Facility from the original stock. The animals were 
housed in polypropylene cages (43 x 22.5 x 20.5 cm; six rats/cage) in climate and access controlled 
rooms (22-24 °C; 50 % humidity). The day/ night cycle was 12 h/12h. Food and water were provided 
ad libitum. The food was standard maintenance diet for rats purchased from Emirates Feed Factory 
(Abu Dhabi, UAE). Ventricular myocytes were isolated from adult male Wistar rats (264 ± 19 g) 
according to previously described technique(Howarth et al., 2002). Briefly, the animals were 
euthanized using a guillotine and hearts were removed rapidly and mounted for retrograde perfusion 
according to the Langendorff method. Hearts were perfused at a constant flow of 8 ml g heart-1 min-1 
and at 36-37  ˚C  with  a  solution  containing  (mM):  130  NaCl,  5.4  KCl,  1.4  MgCl2, 0.75 CaCl2, 0.4 
NaH2PO4, 5 HEPES, 10 glucose, 20 taurine, and 10 creatine set to pH 7.3 with NaOH. When the heart 
had stabilized perfusion was continued for 4 min with Ca2+-free isolation solution containing 0.1 mM 
EGTA, and then for 6 min with cell isolation solution containing 0.05 mM Ca2+-, 0.75 mg/ml 
collagenase (type 1; Worthington Biochemical Corp, USA) and 0.075 mg/ml protease (type X1 V;  
Sigma, Germany). Ventricles were excised from the heart, minced and gently shaken in collagenase-A
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containing isolation solution supplemented with 1 % BSA. Cells were filtered from this solution at 4 
min intervals and resuspended in isolation solution containing 0.75 mM Ca2+. 
Measurement of Na+ and L-type Ca2+ Currents: Currents were measured using whole-cell patch 
clamp technique and recorded with an Axopatch 200B amplifier (Molecular Devices, Downington, PA, 
USA) linked to an A/D interface (Digidata 1322; Molecular Devices). Currents were filtered at 5 kHz 
and acquired using Clampex 8.2. Patch pipettes were fabricated from filamented GC150TF borosilicate 
glass (Harvard Apparatus, Holliston, MA, USA) on a horizontal puller (Sutter Instruments Co., Novato, 
CA).  Electrode  resistances  ranged  from  2.0  to  3.0  MΩ,  and  seal  resistances  were  1-5  GΩ.  After  giga  
seal formation, the membrane was ruptured with gentle suction to obtain whole cell voltage-clamp 
configuration. In recording of Na+   currents, cells were held at -80 mV and were depolarized with 50 
ms pulses from -80 mV to +70 mV in 10 mV increments. Extracellular solution for recordings of Na+ 
currents consisted of (in mM): 100 TEACl, 40 NaCl, 10 glucose, 1 MgCl2, 5 CsCl, 0.1 CaCl2, 1 NiCl2, 
and 10 HEPES (adjusted to pH 7.3 with CsOH). Intracellular solution contained (in mM) 135 CsCl, 5 
NaCl, 10 EGTA, 10 HEPES and 1 MgATP (adjusted to pH 7.25 with CsOH). For recording of Ca2+ 
currents, data were elicited from  a  holding  potential  of  −50  mV  to  membrane  potentials  ranging  from  -
70 mV to +70 mV in 10 mV increments every 300 ms. The whole-cell bath solution contained (in 
mM): 95 NaCl, 50 TEACl, 2 MgCl2, 2 CaCl2, 10 HEPES and 10 glucose (adjusted to pH 7.35 with 
NaOH). The pipette solution contained (in mM): 140 CsCl, 10 TEACl, 2.0 MgCl2, 2 HEPES 1 MgATP 
and 10 EGTA (adjusted to pH 7.25 with CsOH). Experiments were performed at room temperature 
(22–24 ºC). Changes of external solutions and application of drugs were performed using a multi-line 
perfusion system with a common outflow connected to recording chamber. Electrophysiological data 
were analyzed using pClamp 10.2 (Molecular Devices, Union City, CA) and Origin 7.0 (OriginLab 
Corp., Northampton, MA) software. The amplitudes of the currents were normalized to the cell A
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membrane capacitance to provide current densities (nA/pF). The Gi/o protein blocker pertussis toxin 
(PTX; 2µg/ml) was purchased from Sigma. Cells were incubated with PTX for 3 h at 37°C (control 
cells to this group were incubated in the same conditions with distilled water only). 
Radioligand Binding Studies with [3H]BTX-B: Myocytes were prepared daily from adult rat 
ventricles with a yield of 8-10 x 106 myocytes/heart, of which 75-80% were viable rod-shaped striated 
cells. Cells were collected by gentle centrifugation (40 x g) for 5 min, rinsed twice with incubation 
solution, stored at room temperature (21-23 °C) in incubation solution and used within 30 min.  
Myocytes (5 x 105 per assay) in 200 µl of incubation buffer (minimal essential medium (MEM) with 50 
µM CaCl2) were incubated (in duplicate or triplicate in polypropylene centrifuge tubes) with 1 µM sea 
anemone toxin (ATX), 100 µM tetrodotoxin (TTX), and various concentrations of [3H]BTX-B for 60 
min at 37°C in the cell-culture incubator. TTX was added to prevent depolarization induced by Na+ 
influx induced by the toxins (Sheldon et al., 1986). Various concentrations of metAEA dissolved in 
ethanol were added in volumes of 3-5 µl to the incubation buffer (The same volumes of ethanol were 
added to the control samples). These volumes of ethanol had no effect on the [3H]BTX-B binding). 
Assays were done in parallel with tubes containing 0.4 mM aconitine to define nonspecific binding. At 
the end of the 60-min incubation period, 150 µl of the reaction mixture (cell suspension) from each 
sample were filtered through a Whatman GF/C 25-mm fiber-glass filter under vacuum. The reaction 
was terminated by adding 10 ml of Krebs-Henseleit-BSA buffer (127 mM NaCl, 2.3 mM KC1, 1.30 
mM KH2PO4, 1.2 mM MgSO4, 25 mM NaHCO3, 10 mM glucose, 50 µM CaCl2, 1% BSA) equilibrated 
with 95% O2 + 5% CO2 and incubated at 37 °C for 1 mm, then filtered through a Whatman GF-C 24-
mm fiber-glass filter and washed four times with 5 ml of rinse buffer (25 mM Tris-Cl, pH 7.4, 130 mM 
NaC1, 5.5 mM KCI, 0.8 mM MgSO4, 5.5 mM glucose, 50 µM CaCl2). The filters were then dried and 
counted in Econofluor-2 scintillation fluid (PerkinElmer Inc., Waltham, MA, USA) and assessed for A
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cell-bound radioactivity in a Beckman LS-6000SC liquid scintillation counter. (The counting efficiency 
was 48-50%). Specific binding was calculated as the difference between total and nonspecific binding. 
Under these conditions nonspecific binding was 20-30% of total binding at 30 nM [3H]BTXB. The 
dissociation constant (Kd) and maximal binding (Bmax) were determined by Scatchard analysis.  
Specific activity of [3H]BTX-B was 41.3 Ci/mmol; 1 Ci = 37 GBq) was from New England Nuclear. 
Sea anemone toxin and TTX were obtained from Sigma-Aldrich. metAEA was dissolved weekly in 
ethanol at the concentration of 10 mM and stored at -20°C. 
Preparation of cardiac muscle membranes: Cardiac membranes were prepared from the heart of 
adult male Wistar rats by some modifications of previously described methods (Dunn, 1989; Oz et al., 
2000). Briefly, rat heart was minced with scissors and washed two times with ice-cold binding buffer to 
remove extraneous blood. The tissue (one heart in a 50-ml) was placed in plastic centrifuge tube 
containing 10 ml ice-cold buffer (50 mM Tris⋅Cl, pH 7.2) and homogenized on ice by two 5-sec bursts 
in a Polytron homogenizer at setting 5. The solution was decanted to a motor-driven 10-ml glass-Teflon 
homogenizer and homogenized on ice by 10 passes at setting 8. The homogenate was filtered through 
four layers of cheesecloth (to remove tissue debris) into a clear 50-ml centrifuge tube and centrifuged 
for 45 min at 45,000 × g, 4°C. The pellet was suspended in 5 ml ice-cold binding buffer for each rabbit 
heart by homogenizing the pellet five times on ice with a motor-driven 10-ml glass-Teflon 
homogenizer at setting 5. Membrane protein concentration was determined using the Bradford method 
using BSA as a standard. The membranes were diluted in binding buffer to 1 mg protein/ml and store in 
5-ml aliquots at -70°C. 
Radioligand Binding Studies with [3H]Isradipine: Experiments on the binding of [3H]Isradipine 
(Specific activity 58.6 Ci /mmol, New England Nuclear, Chadds Ford, PA, USA) were conducted 
similar to our earlier studies (Oz et al., 2000). Briefly, aliquots of membranes (0.1 mg) were added to A
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different concentrations of radiolabeled ligand to give a final concentration of 0.02 mg/ml membranes 
in a total volume of 0.8 ml. After 60 min incubation at room temperature, 0.4 ml aliquots of each 
sample were filtered under vacuum through Watman GF\C filters and rapidly washed with 5 ml of ice-
cold assay buffer. The filters were dried and extracted in 5 ml of HydroflourTM (National Diagnostics, 
St. Louis, MO, USA) scintillation fluid before counting for 3H. Triplicate 50-μl  samples  of  the  
incubation mixtures were also counted directly for estimations of total binding. Nonspecific binding 
was  estimated  from  parallel  measurements  of  binding  in  the  presence  of  5  μM  unlabeled  nifedipine.  
MetAEA, AEA, AM251, and AM630 were purchased from Tocris (Ellisville, MO, USA). All other 
materials mentioned were purchased from Sigma-Aldrich (St. Louis, MO, USA). In patch clamp 
experiments, ethanol concentrations in control and in presence of AEA, metAEA and AM251 were in 
the range of 0.007- 0.07 % v/v. AM630 was dissolved in DMSO and the final concentration for DMSO 
used in the experiments did not exceed 0.007% (v/v). Stock solutions of AEA, AM251 and AM630 
were kept at -20 °C until their use. Ethanol at the concentration range used in our experiments had no 
effect on the specific binding of [3H]BTX-B and [3H]Isradipine. 
Data Analysis: The results of the experiments were expressed as mean ± standard error of the mean 
(S.E.M.). Statistical analysis was performed using the paired t-test (within the same cell analysis). 
Statistical significance among groups was determined using one way ANOVA followed by Benferonni 
Post-hoc analysis. Statistical analysis of the data was performed using Origin 7.0 software (OriginLab 
Corp., Northampton, MA) and IBM SPSS statistics version 20. On all graphs (*) denotes statistical 
significance with P<0.05, between specified values, or if not specified to the respective control. 
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RESULTS 
The passive properties of the ventricular cells from controls were not significantly different 
from those of the AEA treated cells. Resting membrane potentials (mean ± SEM) were -76.2 ± 1.3 and 
-78.3 ± 1.5 mV in control (n=38) and AEA treated (n=53) myocytes, respectively. The mean cell 
capacitance in the control group was 117.2 ± 14.7 pF, whereas in the AEA treated cells was 108.3 ± 
12.1  pF.  The  input  resistance  (measured  close  to  the  resting  potential)  was  72.4  ±  16.5  MΩ  in  the  
control  cells  and  79.3  ±  17.8  MΩ  in  AEA-treated cells. In control cells, these passive membrane 
properties were not altered significantly in experiments lasting up to 25 to 30 min. In 18 control cells 
measured, resting membrane potentials, cell capacitance, and input resistance after 25 min of 
experiment were -74.8 ± 3.4 mV, 109.6 ± 14.3 pF, and 81.2  ±  14.3  MΩ,  respectively.  These  values  
were not significantly different from control values obtained within the first 5 min of patch-clamp 
experiment (n=18; paired t-test, P>0.05). Characteristics (threshold, maximal, and reversal potentials) 
of current-voltage relationship remained stable during the experiments.   
Effects of AEA on voltage-dependent Na+ channels: 
Previous studies have indicated that AEA has significant antiarrhythmic effects suggesting that 
this compound may affect voltage activated inward Na+ (INa) and Ca2+ (IL,Ca ) currents of ventricular 
myocytes. To verify these possibilities, we have conducted a series of experiments under conditions 
that enable reliable isolation of either INa or ICa in voltage-clamp mode. In the first set of experiments, 
INa was typically elicited by pulses from -80 mV to -20 mV for 50 ms. Figure 1A shows recordings of 
INa in ventricular myocytes before, during and after application of 10 µM AEA. The effect of AEA was 
detectable at 2-3 min and reached a steady-state level within 10-15 min (Fig. 1B). The recovery was A
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partial during the experiments lasting up to 25 to 30 min (Fig. 1B). In our studies, AEA was dissolved 
in ethanol, and therefore we have tested the effect of ethanol as a vehicle. In agreement with earlier 
studies (Danziger et al., 1991; Bebarova et al., 2010), our results indicated that maximal amplitudes of 
INa were altered after 10 min vehicle application in experiments lasting up to 20 to 25 min. Due to the 
effect of vehicle, we have tested each concentration of AEA and vehicle separately and plotted the 
concentration response curve after the subtraction of vehicle effect (Supplement Figure 1). The effect of 
increasing AEA and corresponding ethanol concentrations and corrected concentration-response curve 
were presented in supplement Figure 1. In order to exclude the possibility of the involvement of 
degradation products of AEA in the inhibition of Na+ current, the effect of  10 µM metAEA was tested. 
metAEA caused a significant inhibition of Na+ currents (36 ± 4 % inhibition of controls; n=5; paired t-
test). 
With 40 mМ  Na+ outside and Cs+ as the major intracellular cation, inward INa in response to 
incremental step depolarizations (Vm, 10 mV increment) applied from a holding potential Vh = -80 mV 
started to activate at Vm= -50 mV, and reached maximal amplitude at Vm = -30 mV. At more positive 
potentials the inward current decreased reversing its direction at an apparent reversal potential (Vrev) of 
around +60 mV. Traces of INa in the absence and presence of 10 µM AEA were presented in Figure 1C. 
AEA inhibited INa without causing significant changes in the I-V relationship. The current–voltage (I-V) 
relationship for INa was illustrated in Figure 1D. AEA inhibited INa without changing the threshold, 
peak and reversal potentials. 
Steady-state activation (SSA) curves of INa before and after AEA application were derived by 
fitting the respective I-V relationships with the product of Boltzmann and Goldman-Hodgkin-Katz 
(GHK) equations of which the first one describes voltage-dependence of SSA, and the second one the 
current through open channels. This allowed us to determine if AEA influences the parameters of INa A
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SSA-the voltage of half-maximal activation (V1/2) and slope factor (k). In controls, V1/2 and k values 
were -45.2 mV and 7.1 mV, respectively. In the presence of 10 µM AEA, V1/2 and k values were -42.3 
mV, and 7.5 mV (Fig. 2A). There were no statistically significant differences between controls and in 
the presence of AEA (ANOVA, n=8-10; P>0.05). 
In order to determine if AEA influences the properties of voltage gated sodium channels 
(VGSCs) inactivation, we compared steady-state inactivation (SSI) dependencies of INa in the absence 
and presence of AEA. SSI-curves were acquired using a standard voltage protocol consisting of 
prolonged (400 ms) conditioning pre-pulse to various Vm in the range of -100 mV to +70 mV which 
was immediately followed by the constant INa-activating test pulse to Vm = -20 mV. SSI-dependency 
was plotted as normalized amplitude of INa at Vm= -20 mV against the value of conditioning Vm 
(normalization was performed to the amplitude of INa at conditioning Vm= -100 mV). The fit of the 
obtained data points using the Boltzmann equation (Fig. 2B) has indicated that under control conditions 
SSI of INa is V1/2= -70.2 mV and k= 5.8 mV, and in the presence of 10  μM  of  AEA,  V1/2= -81.4 mV and 
k=5.1 mV. Thus, AEA induced a significant hyperpolarizing shift in the voltage-dependence of SSI of 
cardiac VGSCs (-11.4 mV; paired t-test, P<0.05). Comparison of INa currents in the absence and 
presence of AEA revealed noticeable acceleration of the current's inactivation kinetics by AEA. 
Quantification of the time constant of INa inactivation  (τi, Fig. 2C) by fitting the currents' decay phase 
with  exponential  functions  showed  that  AEA  (10  μM)  significantly  reduced  τi in the range of Vm 
between -50 mV and +20 mV (Fig. 2C). 
The rat heart has been shown to expresses CB1 and CB2 receptors (Bouchard et al., 2003). 
Therefore it was likely that the effect of AEA is mediated by the activation of these receptors. For this 
purpose we have chosen two antagonists (AM251 and AM630) for their relative selectivity for CB1 
versus CB2 receptor (Lan et al., 1999; Ross et al., 1999) deﬁned in accordance with the nomenclature A
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of the Guide to Receptors and Channels (Alexander et al., 2011). In the presence of 0.3 µM AM251, a 
CB1 antagonist with Ki of 7.5 nM (Lan et al., 1999) and 0.3 µM AM630, a CB2 antagonist with Ki of 
32.1 nM (Ross et al., 1999), AEA (10 µM) inhibition of INa remained unaltered (n=6-8, data not 
shown). Since the known cannabinoid receptors CB1 and CB2 [for a review (Pertwee et al., 2010)] are 
coupled to pertussis toxin (PTX) sensitive Gi/o type G-proteins, we have tested whether the inhibitory 
effect of AEA on INa can be modulated by PTX pretreatments. Our results show that the extent of the 
inhibitory effect of AEA on the maximal amplitudes of INa was not affected by PTX pretreatment (Fig. 
2D). There were no statistically significant difference in the % inhibition by AEA in control and PTX-
treated groups (n=6-8; ANOVA; P>0.05). In positive control experiments, PTX, as it has been reported 
earlier (Zhang et al., 2005) effectively attenuated the inhibitory actions of BRL-37344,  a  β3  adrenergic  
receptor agonist, on L-type voltage-gated Ca2+ currents recorded in ventricular myocytes (supplement 
Figure 2). These results indicate that G-proteins are functionally coupled to their target receptors. 
Effect of metAEA on [3H]BTX-B binding: 
The results of electrophysiological experiments suggest that AEA can directly interact with 
VGSCs. For this reason, we have conducted radioligand binding experiments to test the possibility of 
direct interaction between AEA and VGSCs in cardiomyocytes. Binding of [3H] Batrachotoxin in 
cardiomyocytes (Sheldon et al., 1986; Kang and Leaf, 1996) and neuronal structures (Postma and 
Catterall, 1984) has been well characterized in earlier investigations. In this study, due to long 
incubation times (up to 60 min), we have tested the effect of methanandamide (metAEA), a non-
hydrolysable AEA analogue (Abadji et al., 1994), to avoid likely confounding effects of degradation 
products and oxygenated metabolites on the specific binding of [3H]batrachotoxinin A-20α-benzoate 
([3H]BTX-B) in rat ventricular cardiomyocytes.  A
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Equilibrium curves for the binding of [3H]BTX-B, in the presence and absence of  metAEA are 
presented in Figure 3A (n= 8-11).  At  a  concentration  of  10  μM,  metAEA  caused  a  significant  inhibition  
of the specific binding of [3H]BTX-B. In  controls  and  in  presence  of  10  μM  metAEA,  maximum 
binding activities (Bmax) were 76 ± 6 and 41 ± 4 fM, and KD values were 32 ± 4 and 35 ± 3 nM, 
respectively. There was a statistically significant difference between control and metAEA treated 
groups with respect to Bmax values (n=8-11; ANOVA; P<0.05). Effect of metAEA on saturation 
binding was further analyzed by Scatchard analysis (Fig. 3B), which yielded a Bmax of 92 fmol and a 
Kd of 21 nM [3H]BTX-B for controls and a Bmax of 43 fmol and a Kd of 24 nM for cells treated with 
metAEA. To further determine the effects of metAEA on the binding of [3H]BTX-B to cardiac Na+ 
channels, myocytes were incubated with [3H]BTX-B in the presence of increasing metAEA 
concentrations. The results indicated that the metAEA inhibited the specific binding of [3H]BTX-B in a 
dose-dependent manner with an IC50 of 8.6 µM and slope of 1.1 (Fig. 3A). We have also investigated 
the effect of CB receptor antagonists AM251 (1µM) and AM630 (1µM) on the specific binding of 10 
nM [3H]BTX-B. Results presented in Figure 3D indicate that the effect of metAEA (10 µM) on the 
specific binding of [3H]BTX-B was not significantly altered in the presence AM251 or AM630 
(compared to AEA alone, n=7-11; ANOVA; P>0.05). Incubation with AM251 or AM630 alone did not 
significantly alter the specific [3H]BTX-B binding from cardiac muscle membranes (ANOVA; n=7-11; 
P>0.05) 
Effect of AEA on L-type Ca2+ currents:  
We have also investigated the effect of AEA (1 µM) on the L-type Ca2+ currents (IL,Ca). Figure 
4A shows a typical record of IL,Ca elicited by applying a single 300 ms voltage pulse to +10 mV from a 
holding potential of -50 mV in rat ventricular myocyte before and after 10 min superfusion with 1µM 
AEA. Time course of the effect of AEA on the density of IL,Ca was presented in Figure 4B. Current A
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density of IL,Ca were also altered after 10 min vehicle application in experiments lasting up to 20 to 25 
min. Effects of increasing AEA and corresponding ethanol concentrations on IL,Ca and corrected 
concentration-response curve were presented in supplement Figure 3. The effect of 1µM metAEA was 
also tested. metAEA caused a significant inhibition of Ca+2 currents (46 ± 4 inhibition of controls; n=5; 
paired t-test). 
The effects of AЕА  were  also  investigated  on  the  biophysical  properties  of  IL,Ca in rat 
ventricular myocytes. IL,Ca was recorded in the presence of intracellular Cs+ and extracellular TEA+ to 
suppress K+ currents while retaining 95 mM Na+ in the extracellular solution. Elimination of 
contaminating Na+ current during recording of IL,Ca was achieved by applying voltage step-pulses from 
relatively depolarized Vh of -50 mV, which produced steady-state INa inactivation (Voitychuk et al., 
2012). As evident from original recordings and I-V relationships (Fig. 4C, D), IL,Ca had much slower 
kinetics in response to step depolarization and activated at more positive potentials than INa: it started to 
appear at Vm = -30 mV, reached maximum at around Vm = +10 mV, and decreased at higher voltages 
approaching zero at about Vm = +60 mV (Fig.4D). 
AEA also produced a depolarizing shift of IL,Ca SSA by 12.6 mV (i.e., from control value V1/2= 
-9.4 ± 0.3 mV to V1/2= +3.2 ± 0.2 mV in the presence of AEA) and hyperpolarizing shift of IL,Ca SSI by 
4.3 mV (i.e., from control value V1/2= -18.9 ± 0.1 mV to V1/2= -23.2 ± 0.1 mV in the presence of AEA) 
with little influence on the slopes of respective dependencies (k=7. 2 ± 0.4 mV and k=-5.3 ± 0.3 mV for 
the control activation and inactivation, respectively, vs. k=6.9 ± 0.3 mV and k=-5.1±0.2 mV for the 
AEA-modified activation and inactivation, respectively), which altogether resulted in the notable 
reduction of I L,Ca “window  current”  responsible  for  the  stationary  Ca2+ entry in the range of membrane 
potentials from -40 mV to +10 mV (Fig. 5A, B). Thus, the mechanism of AEA action on cardiac L-type 
voltage gated calcium channel (VGCC) most likely involves influence on channel gating that reduces A
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“window  current”  as  well  as  partial  blockade  of  the  ion-conducting pathway that decreases current 
amplitude. In time matching controls measured after 10 min of ethanol application, activation and 
inactivation parameters was not significantly different compared to time-matched controls (without 
ethanol application after 10 to 15 min of patching time). V1/2 values for activation and inactivation were 
-10.3 ± 0.4 mV and  -20.6 ± 0.7 for controls, and -9.7 ± 0.6 mV and  -19.6 ± 0.8 in the presence of 
0.007% (1.5 mM) ethanol, respectively (n=7-9; ANOVA, P>0.05).  
In line with earlier reports (Soldatov et al., 1998), kinetic analysis of I L,Ca currents were fit to 
double-exponential  function  with  fast  (τf)  and  slow  (τs) inactivation time constants. Comparison of I L,Ca 
currents in the absence and presence of AEA revealed noticeable acceleration of the current's 
inactivation kinetics by AEA. Quantification of the time constants of I L,Ca  inactivation showed that 
AEA  (1  μM)  significantly  reduced  τi in the range of Vm -30 mV and +10 mV (Fig. 5C). 
In earlier electrophysiological studies, sidedness of AEA actions on various ion channels has 
been reported (Oz, 2006). For this reason, we have tested the effect of intracellular application of AEA 
by including AEA (1 µM) inside the patch electrode (Fig. 5D). The extent of AEA inhibition 
(compared after 15 min of AEA exposure) was not significantly different between intracellular and 
extracellular AEA applications (ANOVA; n=11-14; P>0.05). We have also conducted experiments 
with URB597, a potent inhibitor of FAAH which is the enzyme that hydrolyzes AEA (incubation of 1 
µM URB597 for 45 min at 37 °C versus controls incubated with 0.007 % ethanol alone for 45 min at 37 
°C). Our results indicate that the effect of 1 µM AEA on L-type Ca2+ currents remained unaltered in 
URB597-incubated cells. The extent of AEA inhibition was in the presence and absence of URB597 
treatment was 35 ± 4 % and 32 ± 3 %, respectively (n=5-7; ANOVA, P>0.05). A
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In the next series of experiments, we tested if the modulation of Ca2+ binding site can mediate 
the effect of AEA on the inactivation kinetics of L-type VGCCs. For this purpose, we have replaced 
extracellular Ca2+ with Ba2+ and tested the effect of AEA on Ba2+ currents (IBa) through L-type VGCCs. 
In line with earlier studies (Soldatov et al., 1998), inactivation of IBa fit to mono-exponential decay 
function (Fig. 6A) with significant voltage-dependency. In the presence of AEA, inactivation time 
constant (Fig. 6A and 6B), and the maximal amplitudes of IBa were significantly inhibited compared to 
control values (paired t-test; n=7; P<0.05). 
We have also investigated whether the inhibitory effects of AEA on L-type VGCCs are 
mediated by the activation of cannabinoid receptors.  Since the known cannabinoid receptors CB1 and 
CB2 [for a review (Pertwee et al., 2010)] are coupled to pertussis toxin (PTX) sensitive Gi/o type G-
proteins, we have tested whether the inhibitory effect of AEA on L-type VGCCs can be modulated by 
PTX pretreatments. Our results show that the inhibitory effect of AEA on the maximal amplitudes of 
IL,Ca was not affected by PTX pretreatment (Fig. 6C). We have conducted further experiments in which 
1 mM GTP was included in the pipette solution. In the presence of GTP, AEA (10 min bath 
application) continued to inhibit L-type Ca2+ currents to 62 ± 4 % of controls (n=6). Furthermore, in the 
presence of 0.3 µM AM251, a CB1 antagonist with Ki of 7.5 nM (Lan et al., 1999) and 0.3 µM 
AM630, a CB2 antagonist with Ki of 32.1 nM (Ross et al., 1999), AEA (1µM) inhibition of IL,Ca 
remained unaltered (Fig. 6D). There were no statistically significant difference in the % inhibition by 
AEA among AEA, AEA+AM251, and AEA+AM630-treated groups (n=6-9; ANOVA; P>0.05).  
Application of AM251 or AM630 alone did not have a significant effect on the amplitudes of IL,Ca (Fig. 
6D) (n=8; Paired t-test; P>0.05).   
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Effect of metAEA on [3H]Isradipine binding: 
In cardiac tissue, AEA is hydrolyzed to arachidonic acid (AA), and AA is known to inhibit the 
function of cardiac L-type Ca2+ channels and cause negative inotropic actions (Li et al., 2009); for a 
review of earlier studies, (Oz, 2006). Therefore it was possible that AA, rather than AEA, interacts with 
L-type Ca2+ channels. For this reason, we tested the effect of metAEA, the metabolically stable chiral 
analogue of AEA which is resistant to hydrolytic inactivation by fatty acid amide hydrolase (Abadji et 
al., 1994) on the specific binding of [3H]Isradipine.  Equilibrium curves for the binding of 
[3H]Isradipine, in the presence and absence of the metAEA are presented in Figure 7A (n= 8-11). At a 
concentration  of  10  μM,  metAEA  caused  a  significant  inhibition  of  the  specific  binding  of  
[3H]Isradipine. In  controls  and  in  presence  of  10  μM  AEA,  Maximum binding activities (Bmax) were 
126 ± 19 and 58 ± 24 fM/mg protein, and KD values were 75 ± 12 and 86 ± 14 pM, respectively. There 
was a statistically significant difference between control and metAEA treated groups with respect to 
Bmax values (P<0.05, ANOVA, n=8-11). Effect of metAEA on saturation binding was further 
analyzed by Scatchard analysis (Fig. 7B), which yielded a Bmax of 178 ± 19 fmol/mg protein and a Kd 
of 78 ± 8 pM [3H]Isradipine for controls and a Bmax of 68 ± 9 fmol/mg protein and a Kd of 76 ± 8 pM 
for membranes treated with metAEA. The effect of increasing metAEA concentrations was also 
investigated on the specific [3H]Isradipine binding from cardiac muscle membranes (Fig. 7C). In the 
concentration  range  used  (0.1  to  30  μM),  metAEA  caused  a  significant  inhibition  of  the  specific  
binding of [3H]Isradipine. The values for IC50 and  slope  factor  for  metAEA  were  3.6  μM  and  1.4,  
respectively. 
Effects of CB receptor antagonists on the specific [3H]Isradipine binding from cardiac muscle 
membranes,  were  also  investigated.  Compared  to  controls,  inhibitory  effect  of  metAEA  (10  μM)  on  the  A
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specific binding of [3H]Isradipine was not altered by incubation (30 min) with  AM251 or AM630 (1 
μM)  (Fig.  7D)  (ANOVA;;  n=8-10; P>0.05). Incubation with AM251 or AM630 alone did not 
significantly alter the specific [3H]Isradipine binding from cardiac muscle membranes (ANOVA; n=8-
10; P>0.05) 
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DISCUSSION: 
The results of this study indicate for the first time that previously reported actions of AEA on 
cardiac muscle contractility (negative inotropic effect) and the action potential (AP) configuration 
involves direct inhibition of voltage-dependent Na+ and Ca2+ channels in ventricular myocytes. Actions 
of endocannabinoids on cardiovascular system influence multiple organ systems and involve complex 
set of cellular and molecular mechanisms (Malinowska et al., 2012; Randall et al., 2004). In addition to 
cannabinoid receptor-mediated actions, several other factors such as the activation of autonomic 
reflexes, the presence of endothelial cells and fatty-acid based metabolic products have been reported to 
contribute to the complexity of endocannabinoid actions on the heart. On the other hand, acutely 
dissociated ventricular myocytes have several advantages over in-vivo and traditional in-vitro 
conditions, since it excludes the influences of reflex pathways, autonomic nerve endings, 
neurotransmitter uptake system, gap-junction connections, and coronary perfusion status.  
In our experiments, AEA caused a significant reduction in the maximal amplitudes of both Na+ 
and Ca2+ currents. Inhibitory effect of AEA, on VGSC, which is the major inward current during the 
upstroke (phase 0) of the AP is in agreement with our recently published current-clamp studies (Al 
Kury et al., 2014) indicating that AEA decreases the amplitude and initial rate of rise of the AP in 
ventricular myocytes. The results suggest that the effect of AEA on VGSC is not mediated by CB1 or 
CB2 cannabinoid receptors. Furthermore, radioligand binding experiments indicate that AEA can 
interact directly with VGSC in ventricular myocytes. In cardiac muscles, VGSCs are almost 
exclusively represented by their TTX-resistant Nav1.5 isoform (gene SCN5A; (Catterall et al., 2005a)). 
Therefore, the changes in the biophysical properties of INa by AEA, namely induction of the 
hyperpolarizing shift in the voltage-dependence of its steady-state inactivation (SSI) can be attributed 
to their effects on Nav1.5 channel gating.  A
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A hyperpolarizing shift of the SSI indicates that a higher proportion of VGSCs would be 
inactivated at resting membrane potential and therefore substantially fewer channels would be available 
for activation, resulting in decreased amplitude and rate of rise during the upstroke of the AP.  
Our radioligand studies indicated that [3H]BTX-B binding was inhibited by AEA in an 
allosteric manner. The binding site for [3H]BTX-B has also been shown to interact allosterically with 
local anesthetics and class I antiarrhythmics (Sheldon et al., 1994). Therefore it is likely that AEA 
synthesized during the cell stress can bind to Nav1.5 channel and modulate the actions of local 
anesthetics and class I antiarrhythmics with Nav1.5 channel. Although this, to our knowledge, is the 
first demonstration of the direct inhibitory action of AEA on a muscle type voltage-dependent Na+ 
channel, in several earlier investigations, AEA, at similar or higher concentrations, has been shown to 
inhibit directly the function of voltage-gated Na+ channels in neuronal structures (Kim et al., 2005; 
Duan et al., 2008; Theile and Cummins, 2011; Nicholson et al., 2003). In agreement with our findings, 
both AEA (Theile and Cummins, 2011) and its metabolic product arachidonic acid (Bendahhou et al., 
1997) have been shown to increase inactivation of Na+ channels. Inhibition of VGSCs would slow the 
conduction of depolarization in the heart. However, it is unlikely that the slowed conduction due to Na+ 
channel inhibition alone would result in widening of QT interval observed in rat hearts (Farkas and 
Curtis, 2003).  
In addition to INa, AEA caused a significant inhibition of cardiac IL,Ca, which is mediated by 
Cav1.2 (gene CACNA1C) isoform of L-type VGCCs (Catterall et al., 2005b). This current contributes 
to the plateau of the cardiac AP (phase 2), therefore, its suppression causes both the decrease of the 
amplitude of the plateau and the shortening of the AP duration. In earlier studies, AEA has been shown 
to decrease the amplitude of the plateau and cause shortening of the AP duration [(Li et al., 2009; Al 
Kury et al., 2014]. Our results show that AEA affects activation and inactivation gating of cardiac L-A
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type VGCCs  producing a significant reduction in I L,Ca “window  current”  in  the  range  of  Vm between -
40 mV and +10 mV, and inducing partial blockade of the ion-conducting pathway leading to decreased 
amplitude of ICa. 
Diminished stationary Ca2+ entry as a consequence  of  smaller  “window  current”  may  in  part  
explain AEA-evoked enhancement of cardiomyocytes viability via prevention of Ca2+ overload and 
reduction of necrosis, whereas inhibition of IL,Ca may largely determine the decrease of the AP plateau 
amplitude and AP shortening observed in the presence of AEA. In cardiac muscle, extracellular Ca2+ 
required to trigger Ca2+ release from SR enters through L-type voltage-dependent Ca2+ channels opened 
during the AP. Collectively, these results suggest that during excitation-contraction coupling, the 
inhibition of L-type Ca2+ channels and the decrease in Ca2+-induced Ca2+ release from sarcoplasmic 
reticulum causes negative inotropic effect of AEA reported in earlier studies. In line with this 
hypothesis, although caffeine-induced contractures and myofilament sensitivity to Ca2+ remained 
unchanged, electrically-induced Ca2+ transients were significantly depressed by AEA (Al Kury et al. 
2014), further suggesting that Ca2+-induced Ca2+ release was impaired in the presence of AEA. Overall, 
AEA-mediated suppression of voltage-activated IL,Ca would provide a mechanism for the negative 
inotropic effects observed in earlier studies.  
Mechanism of the inhibitory effect of AEA does not seem to involve Ca2+-induced inactivation 
process, since Ba2+ currents through L-type VGCCs were effectively inhibited by AEA. In addition, 
AEA was equally effective upon intracellular or extracellular application suggesting that there is no 
sidedness for AEA actions on L-type VGCCs. Considering highly lipophilic nature of AEA, it is not 
surprising that AEA can access its binding site from both extra and intracellular sites effectively.  The 
results of radioligand binding and electrophysiological studies indicated that AEA directly interacts 
with and inhibits the function of L-type Ca2+ channels. Although, to our knowledge, this is the first A
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demonstration of the direct effects of AEA on the L-type VGCC in cardiac muscle, similar results 
demonstrating the effects AEA on skeletal muscle L-type VGCCs have also been described in 
biochemical studies (Oz et al., 2000; Oz et al., 2004). In our earlier studies in rabbit skeletal muscle, we 
have demonstrated that AEA inhibits the specific binding of [3H]Isradipine to skeletal T-tubule 
membranes and directly inhibits the functions of skeletal muscle L-type Ca2+ channels (Oz et al., 2000; 
Oz et al., 2004) in a manner that is independent of known cannabinoid receptors. In fact, earlier studies 
searching for endogenous modulators of L-type Ca2+ channels have also identified AEA as a ligand for 
L-type Ca2+ channels (Johnson et al., 1993). Later investigations indicated that effects of AEA are not 
limited to L-type VGCCs in muscles, and other types of Ca2+ currents in neuronal structures are also 
inhibited directly by endocannabinoids such as AEA [for a recent review, (Lozovaya et al., 2009)].   
Involvement of cannabinoid-receptors in the negative inotropic actions of cannabinoids has 
been investigated in several earlier studies [for a recent review, (Batkai and Pacher, 2009)]. However, 
the results of these investigations have not been conclusive [for reviews, (Randall et al., 2004; 
Mendizabal and Adler-Graschinsky, 2007; Malinowska et al., 2012)]. Both cannabinoid receptor 
dependent and independent mechanisms have been suggested (Malinowska et al., 2012). Experiments 
with AEA and the synthetic cannabinoid HU-210 performed in isolated Langendorff rat hearts and in 
isolated, electrically stimulated human atrial appendages (Ford et al., 2002; Bonz et al., 2003) have 
revealed a negative inotropic effect of cannabinoids that may underlie the ability of AEA and HU-210 
to decrease cardiac output as observed in studies performed in vivo (Wagner et al., 2001). In a recent 
study, it was found that a synthetic cannabinoid A-955840 inhibits the function of L-type Ca2+ channels 
in rabbit heart in a manner not sensitive to CB1 and CB2 antagonists (Su et al., 2011). On the other 
hand, in another recent study, AEA was reported to inhibit L-type Ca2+ channels by the activation of 
CB1 receptors (Li et al., 2009). In this study, AEA in the concentration range of 10 nM to 1 µM A
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potently inhibited the function of Ca2+ channels and the effect of AEA was reversed by CB1 receptor 
antagonists. In our experiments, AEA was not effective at concentration lower than 1 µM. In addition, 
in our study, the inhibitory effect of AEA was not reversed by the antagonists of CB1 and CB2 
receptors. Differences between two studies could be due to different strains of rats used (Sprague-
Dawley in their study versus Wistar rats in the present study). Our findings suggest that neither CB1 
nor CB2 receptors are involved in AEA inhibition of L-type Ca2+ channels in rat cardiomyocytes. 
 Although PTX-sensitive signal transduction is well documented for cannabinoid agonists, 
cannabinoid coupling to PTX-insensitive Gq has been reported in several studies (McIntosh et al., 2007; 
Straiker et al., 2002; Ishii and Chun, 2002). Therefore, the effect of AEA through PTX-insensitive 
pathway cannot be excluded. 
AEA belongs to a group of fatty acid-based molecules called long-chain N-acylethanolamines 
(NAEs) which are produced abundantly in response to tissue necrosis and cellular stress (Hansen et al., 
2000;Berger et al., 2004). In fact, accumulation of NAEs was first observed in experimental myocardial 
infarction induced by ligation of coronary arteries in canine heart [(Epps et al., 1979;Epps et al., 1982) 
for a review, (Schmid and Berdyshev, 2002)]. It was demonstrated that NAE content increases up to 
500 nmol/g (approximately 500 μM)  in  infarcted  areas  of  canine  heart  during  ischemia  (Epps et al., 
1979). Although AEA constitutes minor (1-3 %) portion of total NAE levels (Schmid and Berdyshev, 
2002), the results of this study may have important implications regarding the contractile responses of 
ventricular myocytes to ischemia and cellular stress (Hansen et al., 2000; Schmid and Berdyshev, 2002; 
Berger et al., 2004). We have previously reported that major NAEs species including AEA produced 
during ischemia have significant effects on the amplitudes and kinetics of action potentials and 
accompanying ionic currents that could account for the negative ionotropic actions of these compounds 
on ventricular myocytes (Voitychuk et al., 2012). For example, functions of voltage-gated Ca2+ (Oz et A
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al., 2000); (Oz et al., 2004; Oz et al., 2005; Alptekin et al., 2010; Voitychuk et al., 2012) and Na+ 
(Voitychuk et al., 2012; Gulaya et al., 1993) channels have been demonstrated to be modulated by 
NAEs. In the concentration range used in our study, AEA has been shown to inhibit the function of 
various cardiac ion channels in cannabinoid receptor- independent manner. For example, AEA blocks 
T- type Ca2+ channels (Cav3.1 and Cav 3.2) (Chemin et al., 2007) and cardiac Kv1.5 (Barana et al., 
2010) and  Kv4.3 (Amoros et al., 2010) in a receptor- independent manner. These effects may 
contribute to the overall effects of AEA on action potential and myocyte function.  
In conclusion, the results indicate for the first time that AEA interacts directly with Na+ and L-
type Ca2+ channels in ventricular myocytes in a manner that is independent of CB1 and CB2 receptors.   
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FIGURE LEGENDS 
Fig. 1: Effect of AEA on voltage-dependent Na+ currents (INa) in rat ventricular myocytes. 
 (A) AEA inhibits INa recorded using whole cell voltage clamp mode of patch clamp technique. INa was recorded 
during 50 ms voltage pulses to -20 mV from a holding potential of -80 mV. Current traces were recorded before 
(control) and after 10 min application of 10 ìM AEA. (B) Maximal currents of VGSCs presented as a function of 
time in the presence of vehicle (0.07% ethanol) and 10 ìM AEA (n=5-6 cells). (C) Representative recordings of 
INa in response to the depicted pulse protocol under control conditions and after application of 10ìM AEA. (D) 
Normalized and averaged I-V relationships of control INa (filled circles) and INa in the presence of 10 ìM AEA 
(open circles) determined by applying a series of step depolarizing pulses from -80 mV to +70 mV in 10 mV 
increments for a duration of 50 ms. Data points (mean ± S.E.M.) are from 5 to 7 cells.  
Fig. 2: Effect of AEA on steady state activation and inactivation of INa and of pertussis toxin pretreatment 
on AEA inhibition of INa in rat ventricular myocytes .  
(A) Steady-state activation (SSA) and (B) steady-state inactivation (SSI) curves of INa in the absence (filled 
circles) and presence of 1 ìM AEA (open circles).  Fit of experimental data points with Boltzmann equation (see 
text for parameters). (C) Voltage-dependence of INa inactivation time constant (ôi) under control conditions 
(filled circles) and in the presence of 1 ìM AEA (open circles). Data points (mean ± S.E.M.) are from 5 cells. (D) 
Effect of PTX pretreatment on AEA inhibition of the maximal INa amplitudes. Black bars indicate controls. Bars 
present mean ± S.E.M. from 5-8 cells. 
Fig. 3:  Effects of metAEA and cannabinoid receptor antagonists AM251 and AM630 on the specific 
binding of [3H]BTX-B to rat ventricular myocytes.  
(A) Specific binding as a function of the concentration of [3H]BTX-B in the absence and presence of metAEA. 
Data points for controls and metAEA (10 ìM) are indicated by filled circles and open circles, respectively. (B) A
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Scatchard analysis of the effects of metAEA on saturation binding of [3H]BTX-B to ventricular myocytes. The 
slope and intercept of the linear regression curve indicate the KD and Bmax values, respectively. Data points were 
determined from a set of binding experiments presented in the panel A. (C) Effect of increasing metAEA 
concentration on the specific binding of [3H]BTX-B to ventricular myocytes. Binding was measured as described 
in the methods. Data are the means of 5-6 experiments. (D) Effects of cannabinoid receptor antagonists AM251 
(1 ìM) and AM630 (1 ìM)) and their co-application with metAEA (10 ìM) on the specific binding of [3H]BTX-B 
to cardiomyocytes. Bars present mean ± S.E.M. from 7-11 cells. 
Fig. 4: Effect of AEA on Ca2+ currents mediated by L-type Ca2+ channels in rat ventricular myocytes. 
 (A) AEA inhibits L-type Ca2+ currents recorded using whole-cell voltage-clamp mode of patch clamp technique. 
Current traces recorded before (control) and after 10 min application of 1 ìM AEA. ICa were recorded during 300 
ms voltage pulses to +10 mV from a holding potential of -50 mV. (B) Averages of the maximal currents of 
VGCCs presented as a function of time in the presence of vehicle and 1 ìM AEA (n=5 cells; filled circles). 
Application time for the agents was presented in a horizontal bar.  (C) Representative recordings of ICa in 
response to the depicted pulse protocol under control conditions and after application of 1ìM AEA. (D) 
Normalized and averaged I-V relationships of control ICa (open circles) and ICa in the presence of 10 ìM AEA 
(filled circles) determined by applying a series of step depolarizing pulses from -70mV to +70 mV in 10 mV 
increments for a duration of 300 ms. Data points (mean ± S.E.M.) are from 5 to 7 cells. 
Fig. 5: Effect of AEA on steady state activation and inactivation of ICa and of sidedness of AEA application 
on ICa in rat ventricular myocytes.  
(A) Steady-state activation (SSA) and (B) steady-state inactivation (SSI) curves of ICa in the absence (open 
circles) and presence of 1 ìM AEA (filled circles). Data points (mean ± S.E.M.) are from 5 cells. Fit of 
experimental data points with Boltzmann equation. (C) Voltage-dependent fast (triengles) and slow (circles) 
inactivation time constants (ôi) of IL, Ca under control conditions (filled circles, and triangles) and in the presence 
of 1 ìM AEA (open circles and triangles). Data points (mean ± S.E.M.) are from 5-6 cells. (D) Comparison of the A
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intracellular and extracellular application of AEA on the maximal inhibition of ICa. Bars present mean ± S.E.M. 
from 5-8 cells. 
Fig. 6: Effect of AEA on Ba2+ currents mediated by L-type Ca2+ channels, and effects of pertussis toxin 
pretreatment and cannabinoid receptor antagonists on AEA inhibition of L-type Ca2+ channels.  
(A) Traces of normalized Ca2+ and Ba2+ currents through L-type VGCCS. Normalized Ba2+ current in the 
presence 1 µM AEA was presented in the figure. (B) Effect of 1 µM AEA on the maximal amplitudes and the 
inactivation kinetics of Ba2+ currents. Bars present mean ± S.E.M. from 7-8 cells. (C) Percent inhibition of L-
type Ca2+ currents after vehicle (DW) and PTX (2 µg/µl, 3hours). Bars present mean ± S.E.M. from 6-8 cells. 
(D) Effects of CB1 antagonist AM251 (0.3 µM) and CB2 antagonist AM630 (0.3 µM) on AEA (1 µM) 
inhibition of L-type Ca2+ currents. Bars present mean ± S.E.M. from 6-9 cells 
Fig. 7: Effects of metAEA and cannabinoid receptor antagonists AM251 and AM630 on the specific 
binding of [3H]Isradipine to rat ventricular muscle membranes.  
(A) Specific binding as a function of the concentration of [3H]Isradipine in the absence and presence of metAEA. 
Data points for controls and metAEA (10 ìM) are indicated by filled and open circles, respectively. (B)  
Scatchard analysis of the effects of metAEA on saturation binding of [3H]Isradipine binding to cardiac muscle 
membranes. The slope and intercept of the linear regression curve indicate the KD and Bmax values, respectively. 
Data points were determined from a set of binding experiment presented in the panel A. (C) Effects of increasing 
the concentration of metAEA on the specific binding of [3H]Isradipine to cardiac muscle membranes. Data are 
the means of 5-6 experiments.  (D) Effects of cannabinoid receptor antagonists AM251 (1 ìM) and AM630 (1 
ìM)) and their co-application with metAEA (10 ìM) on the specific binding of [3H]Isradipine to T-tubule 
membranes. Bars present mean ± S.E.M. from 5-6 experiments. 
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SUPPPLEMENTS: 
Supplement Fig. 1: Effect of increasing AEA and vehicle (ethanol) concentrations on the voltage-activated 
sodium currents recorded in rat ventricular myocytes.  
(A) Effects of AEA (0.1 to 30 µM) and corresponding vehicle concentrations on the maximal amplitudes of INa 
currents. Each bar represents mean ± S.E.M. from 5 to 7 cells (B) Corrected concentration response curve for the 
inhibitory effect of AEA on INa. The amount of inhibition induced by the vehicle was subtracted from the AEA-
induced inhibition at corresponding AEA concentrations. Data was fit with logistic equation using Origin data 
analysis software. 
Supplement Fig. 2: Effect of pertussis toxin (PTX) pretreatment on BRL-37344 inhibition of voltage 
activated Ca2+ currents (ICa) recorded in rat ventricular myocytes.  
(A) Records of currents presenting the effect of BRL-37344, a â3 adrenercgic receptor agonist, on ICa in the 
absence and presence of PTX (2 µg/ml for 3 hours in 37 °C) pretreatment. Records were obtained by applying a 
step depolarizing pulse from -50 mV to +20 mV for a duration of 300 ms (B) Presentation of results on the effect 
of PTX pretreatment on BRL-37344 inhibition of ICa. Each bar presents mean ± S.E.M. from 5-7 cells.* indicates 
statistically significant difference at the level of P<0.05. 
Supplement Fig. 3: Effects of increasing AEA and vehicle (ethanol) concentrations on the L-type voltage-
activated Ca+2 currents (IL,Ca) recorded in rat ventricular myocytes.  
(A) Effects of AEA (0.1 to 30 µM) and corresponding vehicle concentrations on the maximal amplitudes of IL,Ca. 
Each bar represents mean ± S.E.M. from 5 to 7 cells (B) Corrected concentration response curve for the 
inhibitory effect of AEA on IL,Ca. The amount of inhibition induced by the vehicle was subtracted from the AEA-
induced inhibition at corresponding AEA concentrations. Data was fit with logistic equation using Origin data 
analysis software. Application of AÅÀ inhibited IL,Ca in a concentration-dependent manner with an IC50 = A
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10.2±0.6 ìM, slope factor of 36±0.2, but two-fold higher efficacy (i.e., maximal block at saturating concentration 
À=72.0±2.9%) compared to INa (see supplement figure 1B for comparison). 
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